A detailed history of First Western Trust Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, First Western Trust Bank holds 33,816 shares of BMY stock, worth $1.95 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
33,816
Previous 32,595 3.75%
Holding current value
$1.95 Million
Previous $1.35 Million 29.27%
% of portfolio
0.08%
Previous 0.06%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$39.66 - $51.75 $48,424 - $63,186
1,221 Added 3.75%
33,816 $1.75 Million
Q2 2024

Aug 02, 2024

SELL
$40.25 - $52.99 $29,905 - $39,371
-743 Reduced 2.23%
32,595 $1.35 Million
Q1 2024

May 16, 2024

SELL
$47.98 - $54.4 $26,436 - $29,974
-551 Reduced 1.63%
33,338 $1.81 Million
Q4 2023

Feb 07, 2024

SELL
$48.48 - $57.85 $27,439 - $32,743
-566 Reduced 1.64%
33,889 $1.74 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $94,129 - $105,250
-1,626 Reduced 4.51%
34,455 $2 Million
Q2 2023

Aug 10, 2023

SELL
$63.71 - $70.74 $181,446 - $201,467
-2,848 Reduced 7.32%
36,081 $2.31 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $6,505 - $7,378
-99 Reduced 0.25%
38,929 $2.7 Million
Q4 2022

Feb 10, 2023

BUY
$68.48 - $81.09 $18,695 - $22,137
273 Added 0.7%
39,028 $2.81 Million
Q3 2022

Nov 08, 2022

SELL
$0.13 - $76.84 $65 - $38,420
-500 Reduced 1.27%
38,755 $2.76 Million
Q2 2022

Aug 12, 2022

SELL
$72.62 - $79.98 $247,706 - $272,811
-3,411 Reduced 7.99%
39,255 $3.07 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $2.62 Million - $3.15 Million
42,666 New
42,666 $3.15 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track First Western Trust Bank Portfolio

Follow First Western Trust Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Western Trust Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Western Trust Bank with notifications on news.